Core Viewpoint - The company, 荃信生物-B (02509), announced a share buyback on November 17, 2025, spending HKD 711,900 to repurchase 34,600 shares at a price range of HKD 20.16 to HKD 20.72 per share [1] Summary by Categories Company Actions - 荃信生物-B has executed a share buyback program, indicating a commitment to returning value to shareholders [1] - The total expenditure for the buyback amounts to HKD 711,900, reflecting the company's financial strategy [1] Share Performance - The repurchase price per share ranges from HKD 20.16 to HKD 20.72, which may suggest the company's valuation assessment of its own shares [1] - The total number of shares repurchased is 34,600, which could impact the company's share liquidity and market perception [1]
荃信生物-B11月17日斥资71.19万港元回购3.46万股